COVID-19 vaccines
Everyone, everywhere, should have access to COVID-19 vaccines.
WHO is determined to maintain the momentum for increasing access to COVID-19 vaccines and will continue to support countries in accelerating vaccine delivery, to save lives and prevent people from becoming seriously ill.
Countries should continue to work towards vaccinating at least 70% of their populations, prioritizing the vaccination of 100% of health workers and 100% of the most vulnerable groups, including people who are over 60 years of age and those who are immunocompromised or have underlying health conditions.
- Read WHO’s Global COVID-19 Vaccination Strategy outlining the steps to achieve effective and equitable distribution of vaccines.
- See WHO’s landscape of COVID-19 vaccine candidates for the latest information on vaccines in clinical and pre-clinical development.
- WHO’s COVID-19 dashboard also features the number of vaccine doses administered globally, with more detail provided on the dedicated COVID-19 vaccination dashboard.
- At a regional level, there is an AFRO COVID-19 vaccines dashboard and a PAHO COVID-19 vaccines deliveries dashboard.
- You can follow the status of COVID-19 Vaccines within WHO EUL/PQ evaluation process here.
Public Advice
COVID-19 vaccines explained
COVID-19 questions answered
Advice on getting vaccinated
Q&As
Coronavirus disease (COVID-19): Vaccines Coronavirus disease (COVID-19): Vaccines
Coronavirus disease (COVID-19): Vaccines safety Coronavirus disease (COVID-19): Vaccines safety
Coronavirus disease (COVID-19): Vaccine access and allocation Coronavirus disease (COVID-19): Vaccine access and allocation
Coronavirus disease (COVID-19): Vaccine research and development Coronavirus disease (COVID-19): Vaccine research and development
Coronavirus disease (COVID-19): Use of Emergency Use Listing procedure for vaccines against COVID-19 Coronavirus disease (COVID-19): Use of Emergency Use Listing procedure for vaccines against COVID-19
Vaccines and immunization: What is vaccination? Vaccines and immunization: What is vaccination?
Vaccines and immunization: Vaccine safety Vaccines and immunization: Vaccine safety
Delivering safe and effective vaccines
Regulation and policy
Other resources
Criteria for COVID-19 vaccine prioritization
The proposed attributes and criteria provide considerations for the evaluation and prioritization of COVID-19 candidate vaccines to be considered for further development by WHO. The target audience includes vaccine scientists, product developers, manufacturers, regulators and funding agencies.
Vaccine target product profile
WHO has published the target product profiles for COVID-19 vaccines, which describes the preferred and minimally acceptable profiles for human vaccines for long term protection of persons at high ongoing risk of COVID-19, and for reactive use in outbreak settings with rapid onset of immunity. We have also published the criteria for prioritization of vaccines for clinical trials.